Sncatm2(SNCA)Ge
Targeted Allele Detail
|
Symbol: |
Sncatm2(SNCA)Ge |
Name: |
synuclein, alpha; targeted mutation 2, Gregor Eichele |
MGI ID: |
MGI:7572834 |
Synonyms: |
halphaSyntm2 |
Gene: |
Snca Location: Chr6:60708559-60806839 bp, - strand Genetic Position: Chr6, 29.15 cM
|
Alliance: |
Sncatm2(SNCA)Ge page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:314280
|
Parent Cell Line: |
Not Specified (ES Cell)
|
Strain of Origin: |
129
|
|
Allele Type: |
|
Targeted (Conditional ready, Humanized sequence, Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Sncatm2(SNCA)Ge expresses
1 gene
Knock-in expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
SNCA (6622) |
|
Expresses wild-type human SNCA as well as a low level of read-through mutant C-terminally truncated human SNCA |
|
|
|
Mutation details: A targeting vector consisting of loxP-flanked human alpha-synuclein, followed by a C-terminally truncated human alpha-synuclein lacking 21 amino acids, IRES, a placental alkaline phosphatase (pLAP) reporter gene, and an FRT-flanked neomycin gene was targeted to exon 3, thereby disrupting the mouse gene and placing the wild-type human gene under the control of the endogenous mouse regulatory region. The neomycin selection cassette was removed via flp-mediated recombination. Protein expression of the wild-type human alpha-synuclein is detected, as is the human mutated alpha-synuclein, indicating read-through transcription. However, expression of the human mutant protein is approximately 4-fold lower than in the derivative allele expressing only the mutant SNCA (Sncatm2.1(SNCA*)Ge). The truncation terminates with aspartic acid at residue 119 (120 CCT to TAA) and favors fibrillary aggregate formation.
(J:314280)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Snca Mutation: |
42 strains or lines available
|
|
Original: |
J:314280 Martinez Hernandez A, et al., Low-Expressing Synucleinopathy Mouse Models Based on Oligomer-Forming Mutations and C-Terminal Truncation of alpha-Synuclein. Front Neurosci. 2021;15:643391 |
All: |
1 reference(s) |
|